Table 4.
Country | Year | Survey | TT | IPTp | Syph T&T | Hyp | Fe |
---|---|---|---|---|---|---|---|
Benin |
2013 |
SARA |
18.1 |
20.6 |
6.4 |
9.2 |
25.5 |
Burkina Faso |
2012 |
SARA |
21.2 |
11.9 |
2.0 |
3.6 |
20.3 |
DRC |
2013 |
SARA |
7.2 |
25.1 |
3.9 |
0.9 |
16.1 |
DRC |
2014 |
SARA |
3.7 |
8.9 |
6.7 |
1.0 |
8.4 |
Ghana |
2002 |
SPA |
17.3 |
8.4 |
2.5 |
14.5 |
18.3 |
Kenya |
2004 |
SPA |
11.5 |
13.3 |
7.0 |
0.6 |
11.9 |
Kenya |
2010 |
SPA |
20.9 |
23.3 |
13.5 |
6.8 |
12.8 |
Namibia |
2009 |
SPA |
23.4 |
20.8 |
23.0 |
12.2 |
22.5 |
Rwanda |
2007 |
SPA |
5.8 |
5.6 |
3.2 |
0.1 |
4.8 |
Senegal |
2013 |
SPA |
11.7 |
11.2 |
0.4 |
3.4 |
12.1 |
Senegal |
2014 |
SPA |
13.3 |
13.6 |
1.1 |
5.0 |
14.2 |
Sierra Leone |
2011 |
SARA |
37.3 |
36.3 |
7.0 |
9.0 |
38.0 |
Sierra Leone |
2012 |
SARA |
53.0 |
43.8 |
7.3 |
29.9 |
50.7 |
Sierra Leone |
2013 |
SARA |
52.1 |
54.8 |
12.0 |
28.7 |
52.9 |
Tanzania |
2006 |
SPA |
19.8 |
20.1 |
12.7 |
0.9 |
18.9 |
Tanzania |
2014/15 |
SPA |
8.8 |
6.1 |
5.7 |
3.2 |
9.5 |
Togo |
2012 |
SARA |
14.3 |
15.6 |
4.5 |
1.8 |
16.5 |
Uganda |
2007 |
SPA |
6.8 |
8.2 |
3.2 |
0.9 |
5.4 |
Uganda |
2012 |
SARA |
16.0 |
17.6 |
6.1 |
4.9 |
18.2 |
Zimbabwe |
2014 |
SARA |
64.6 |
42.4 |
59.9 |
50.8 |
68.1 |
Mean | 21.3 | 20.4 | 8.4 | 9.4 | 22.3 |
TT – tetanus toxoid vaccine for pregnant women, IPTp – intermittent preventive treatment of malaria in pregnancy, Syph T&T – syphilis detection and treatment in pregnancy, Hyp – hypertensive disease case management, Fe – iron supplementation
*Source: Service Provision Assessment (SPA) and Service Availability and Readiness Assessment (SARA) surveys.